Pages that link to "Q64378022"

The following pages link to Comparison of adenovirus fiber, protein IX, and hexon capsomeres as scaffolds for vector purification and cell targeting (Q64378022):

Displaying 34 items.

• Transcellular targeting of fiber- and hexon-modified adenovirus vectors across the brain microvascular endothelial cells in vitro (Q28484085) (← links)
• Redundant and synergistic mechanisms control the sequestration of blood-born adenovirus in the liver (Q33713401) (← links)
• Retargeting of adenovirus vectors through genetic fusion of a single-chain or single-domain antibody to capsid protein IX. (Q34120709) (← links)
• Encapsulation of adenovirus serotype 5 in anionic lecithin liposomes using a bead-based immunoprecipitation technique enhances transfection efficiency (Q34146469) (← links)
• Modifications of Adenovirus Hexon Allow for Either Hepatocyte Detargeting or Targeting With Potential Evasion From Kupffer Cells (Q34473365) (← links)
• Modification of adenovirus gene transfer vectors with synthetic polymers: a scientific review and technical guide (Q34697474) (← links)
• Hexon modification to improve the activity of oncolytic adenovirus vectors against neoplastic and stromal cells in pancreatic cancer (Q35096275) (← links)
• Cryoelectron microscopy of protein IX-modified adenoviruses suggests a new position for the C terminus of protein IX. (Q35140014) (← links)
• Targeting EGFR with metabolically biotinylated fiber-mosaic adenovirus (Q36387898) (← links)
• Current advances and future challenges in Adenoviral vector biology and targeting (Q36463004) (← links)
• Adenovirus serotype 5 hexon is critical for virus infection of hepatocytes in vivo (Q36535456) (← links)
• Engineering targeted viral vectors for gene therapy (Q36868494) (← links)
• Furin Cleavage of L2 during Papillomavirus Infection: Minimal Dependence on Cyclophilins (Q37073350) (← links)
• Targeting of adenovirus serotype 5 pseudotyped with short fiber from serotype 41 to c-erbB2-positive cells using bispecific single-chain diabody (Q37227135) (← links)
• Advances and Future Challenges in Adenoviral Vector Pharmacology and Targeting (Q37859842) (← links)
• Tropism-modification strategies for targeted gene delivery using adenoviral vectors (Q38614156) (← links)
• Comparison of the Life Cycles of Genetically Distant Species C and Species D Human Adenoviruses Ad6 and Ad26 in Human Cells (Q38831184) (← links)
• A cathepsin-cleavage site between the adenovirus capsid protein IX and a tumor-targeting ligand improves targeted transduction. (Q39455900) (← links)
• Use of Cre/loxP recombination to swap cell binding motifs on the adenoviral capsid protein IX. (Q39463819) (← links)
• Re-targeted adenovirus vectors with dual specificity; binding specificities conferred by two different Affibody molecules in the fiber (Q39926209) (← links)
• Targeting of adenovirus vectors to the LRP receptor family with the high-affinity ligand RAP via combined genetic and chemical modification of the pIX capsomere (Q39949045) (← links)
• Barriers to systemic application of virus-based vectors in gene therapy: lessons from adenovirus type 5. (Q40103248) (← links)
• Efficient incorporation of a functional hyper-stable single-chain antibody fragment protein-IX fusion in the adenovirus capsid. (Q40176311) (← links)
• Characterization of capsid-modified adenovirus vectors containing heterologous peptides in the fiber knob, protein IX, or hexon (Q40226617) (← links)
• Construction of Metabolically Biotinylated Adenovirus with Deleted Fiber Knob as Targeting Vector (Q41443619) (← links)
• Targeting adenoviruses with factor x-single-chain antibody fusion proteins (Q42533800) (← links)
• Retargeted and detargeted adenovirus for gene delivery to the muscle (Q45874978) (← links)
• Derivation of a triple mosaic adenovirus based on modification of the minor capsid protein IX. (Q45878552) (← links)
• Development of fiber-substituted adenovirus vectors containing foreign peptides in the adenovirus serotype 35 fiber knob (Q45886050) (← links)
• Adenoviral vector with shield and adapter increases tumor specificity and escapes liver and immune control. (Q47547452) (← links)
• Comparison of Liver Detargeting Strategies for Systemic Therapy with Oncolytic Adenovirus Serotype 5. (Q50851488) (← links)
• Designer Oncolytic Adenovirus: Coming of Age. (Q55467684) (← links)
• Tropism and transduction of oncolytic adenovirus 5 vectors in cancer therapy: Focus on fiber chimerism and mosaicism, hexon and pIX (Q59354245) (← links)
• Progress in Adenoviral Capsid-Display Vaccines (Q64376803) (← links)